Inventor · disambiguated record
C. Ronald Kahn
Also filed as: KAHN C RONALD
15 granted patents·14 pending applications·148 citations·filing 1992–2019
91Inventor score
Files withJOSLIN DIABETES CENTER INC16KAHN C RONALD5TSENG YU-HUA2CHILDREN'S MEDICAL CENTER CORP1CHILDRENS MEDICAL CENTER1
Top patents by PatentIndex Score
29 records- 0188US7576052B2Methods and compositions for modulating adipocyte functionJOSLIN DIABETES CENTER INC·Filed 2004·Granted Aug 18, 2009·30 cites·21 claims
- 0284US7825098B2Methods and compositions for modulating Necdin functionJOSLIN DIABETES CENTER INC·Filed 2006·Granted Nov 2, 2010·5 cites·18 claims
- 0377US5260200AIsolated DNA encoding an insulin receptor substrateJOSLIN DIABETES CENTER INC·Filed 1992·Granted Nov 9, 1993·39 cites·7 claims
- 0475US8178492B2Methods and compositions for modulating adipocyte functionKAHN C RONALD·Filed 2009·Granted May 15, 2012·1 cites·1 claims
- 0574US7700555B2Methods of treating diabetesJOSLIN DIABETES CENTER INC·Filed 2007·Granted Apr 20, 2010·3 cites·15 claims
- 0671US9132169B2Methods and compositions for modulating adipocyte functionKAHN C RONALD·Filed 2012·Granted Sep 15, 2015·1 cites·6 claims
- 0769US6322978B1Repeat polymorphism in the frataxin gene and uses thereforeJOSLIN DIABETES CENTER INC·Filed 1999·Granted Nov 27, 2001·48 cites·16 claims
- 0864US9771560B2High-throughput image-based chemical screening in zebrafish blastomere cell cultureCHILDREN'S MEDICAL CENTER CORP·Filed 2013·Granted Sep 26, 2017·0 cites·3 claims
- 0956US2018112182A1High-throughput image-based chemical screening in zebrafish blastomere cell cultureCHILDRENS MEDICAL CENTER·Filed 2017·Application pending·0 cites
- 1055US9346869B2Methods and compositions for inducing brown adipogenesisTSENG YU-HUA·Filed 2014·Granted May 24, 2016·0 cites·6 claims
- 1152US5621075AInsulin receptor substrateJOSLIN DIABETES CENTER INC·Filed 1993·Granted Apr 15, 1997·16 cites·4 claims
- 1252US2008102032A1Methods of Treating Diabetes Using Inhibitors of ARNT2JOSLIN DIABETES CENTER INC·Filed 2007·Application pending·0 cites
- 1352US2009142335A1Methods of diagnosis and treatment of metabolic disordersJOSLIN DIABETES CT·Filed 2008·Application pending·0 cites
- 1451US11519008B2Exosome delivery systemJOSLIN DIABETES CENTER INC·Filed 2019·Granted Dec 6, 2022·0 cites·16 claims
- 1551US2010150885A1Methods and compositions for inducing brown adipogenesisJOSLIN DIABETES CENTER INC·Filed 2006·Application pending·0 cites
- 1650US2004028683A1Modulators of p85 expressionJOSLIN DIABETES CT INC A MASSA·Filed 2003·Application pending·0 cites
- 1750US2009220973A1Obesity and body fat distributionJOSLIN DIABETES CENTER INC·Filed 2007·Application pending·0 cites
- 1849US2014107026A1Bone morphogenetic proteins for the treatment of insulin resistanceJOSLIN DIABETES CENTER INC·Filed 2013·Application pending·0 cites
- 1945US2003013673A1Modulating the Rad-nm23 interactionFiled 2002·Application pending·0 cites
- 2041US9446096B2Glypican-4 based compositions and methods for treating and diagnosing insulin resistanceJOSLIN DIABETES CENTER INC·Filed 2012·Granted Sep 20, 2016·0 cites·10 claims
- 2140US2002051786A1Modulators of p85 expressionFiled 2001·Application pending·0 cites
- 2238US2017173114A1Methods and compositions for induction of ucp1 expressionJOSLIN DIABETES CENTER INC·Filed 2015·Application pending·0 cites
- 2336US2014194353A1Compositions and methods for the treatment of nervous disorders associated with diabetesKAHN C RONALD·Filed 2011·Application pending·0 cites
- 2435US2012135927A1Bone morphogenetic proteins for the treatment of insulin resistanceTSENG YU-HUA·Filed 2010·Application pending·0 cites
- 2535US2015147292A1Novel surface markers for adipose tissueKAHN C RONALD·Filed 2012·Application pending·0 cites
- 2633US2012208750A1Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosisKAHN C RONALD·Filed 2010·Application pending·0 cites
- 2732US6326141B1Methods for determining risk for Type I and Type II diabetesJOSLIN DIABETES CENTER INC·Filed 1997·Granted Dec 4, 2001·4 cites·14 claims
- 2826US5891430ADiabetogene rad: a type II diabetes specific geneJOSLIN DIABETES CENTER INC·Filed 1996·Granted Apr 6, 1999·1 cites·5 claims
- 2925US5589374ADiabetogene rad: a type II diabetes specific geneJOSLIN DIABETES CENTER INC·Filed 1993·Granted Dec 31, 1996·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when C. Ronald Kahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →